Testicular Tissue Cryopreservation (TTC)
ConditionFertility Issues
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
AgeNot listed
SponsorUniversity of Colorado, Denver
About this trial
The "Testicular Tissue Cryopreservation" study is open to a subset of patients facing disease or treatment regimens that could lead to infertility (gonadotoxic therapies). For some of these patients, experimental testicular tissue cryopreservation is the only fertility preservation option available. The overall objective of this study is to determine the feasibility and acceptability of testicular tissue cryopreservation in male patients of all ages who have a condition or will undergo a treatment that can cause infertility.
Eligibility criteria
Qualifiers
Male at any age.
Cyclophosphamide equivalent dose (CED) ≥4 g/m2
Total body irradiation (TBI)
Testicular radiation >2.5 Gy
Disqualifiers
Diagnosed with psychological, psychiatric, or other conditions which prevent giving fully informed consent.
Diagnosed with an underlying medical condition that significantly increases their risk of complications from anesthesia and surgery.
Trial design
Treatments tested in this trial
- Testicular tissue biopsy and cryopreservation
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov